Holen Sie sich die Stockscreener-App
7.9481
0.90%
-0.0719
Verrica Pharmaceuticals Inc Aktie (VRCA) Neueste Nachrichten
Will Verrica Pharmaceuticals Inc. stock see insider buyingRate Hike & Daily Market Momentum Tracking - ulpravda.ru
Will Verrica Pharmaceuticals Inc. (1NE) stock outperform benchmarks2025 Major Catalysts & Accurate Trade Setup Notifications - ulpravda.ru
Verrica doses first patient in phase 3 trial for common wart treatment - Investing.com Nigeria
First Patient Dosed in Phase 3 VP-102 Common Warts Program - Dermatology Times
Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating By Investing.com - Investing.com Nigeria
Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating - Investing.com
Verrica Pharmaceuticals announces first patient dosed in phase 3 program - MarketScreener
Verrica Pharmaceuticals (VRCA) Begins Phase 3 Trials for Common Warts Treatment - GuruFocus
New wart treatment enters Phase 3 testing for 22M U.S. patients - Stock Titan
Verrica Pharmaceuticals adds Caligan Partner to board - MSN
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Short Interest Update - Defense World
Short Interest in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Decreases By 26.2% - MarketBeat
Verrica Pharmaceuticals appoints Charles Frantzreb to board and approves equity grants - Investing.com Canada
Verrica Pharmaceuticals appoints Charles Frantzreb to board and approves equity grants By Investing.com - Investing.com South Africa
Verrica Pharmaceuticals Adds Caligan Partner to Board - TipRanks
Verrica Pharmaceuticals Appoints New Director - TradingView — Track All Markets
Verrica Pharmaceuticals Inc. Appoints Charles Frantzreb as Director, Effective December 26, 2025 - MarketScreener
Can Verrica Pharmaceuticals Inc. stock reach $100 price targetHigh Yield Income Stocks & Low Cost Portfolio Tips - bollywoodhelpline.com
Verrica Pharmaceuticals (VRCA) Stock Price, Quote, News & History - Benzinga
Verrica Pharmaceuticals upgraded to buy from hold at Brookline - MSN
Gains Report: Can Verrica Pharmaceuticals Inc. stock reach $100 price targetJuly 2025 Reactions & Entry Point Confirmation Signals - Улправда
Is Verrica Pharmaceuticals Inc. stock a safe buy before earningsTrade Analysis Report & AI Optimized Trading Strategy Guides - Улправда
Will Verrica Pharmaceuticals Inc. stock pay special dividendsQuarterly Performance Summary & AI Powered Market Entry Strategies - Улправда
Can Verrica Pharmaceuticals Inc. stock surprise with earnings upsideJuly 2025 Outlook & Verified Swing Trading Watchlists - Улправда
Verrica Pharmaceuticals (FRA:1NE0) EV-to-OCF : -4.47 (As of Dec. 19, 2025) - GuruFocus
Can Verrica Pharmaceuticals Inc. stock weather global recessionJuly 2025 Chart Watch & Smart Investment Allocation Tips - Улправда
Why Verrica Pharmaceuticals Inc. stock is favored by top institutions2025 Volatility Report & High Accuracy Swing Trade Signals - bolumsonucanavari.com
Is Verrica Pharmaceuticals Inc. stock supported by innovation pipelineJuly 2025 Trade Ideas & High Accuracy Investment Entry Signals - Улправда
Is Verrica Pharmaceuticals Inc. stock a buy on dipsJuly 2025 Highlights & AI Powered Trade Plan Recommendations - Улправда
Will Verrica Pharmaceuticals Inc. (1NE) stock boost dividends furtherMarket Sentiment Review & Reliable Entry Point Alerts - DonanımHaber
Verrica Pharmaceuticals (NASDAQ:VRCA) Rating Increased to Buy at Brookline Capital Management - Defense World
Brookline Capital upgrades Verrica Pharmaceuticals (VRCA) - MSN
Aug Drivers: Will Verrica Pharmaceuticals Inc. stock see insider buyingMarket Sentiment Review & Weekly Top Gainers Alerts - Улправда
Is Verrica Pharmaceuticals Inc. (1NE) stock undervalued after correction2025 Sector Review & Verified Momentum Stock Alerts - Улправда
Verrica Pharmaceuticals (NASDAQ:VRCA) Stock Rating Upgraded by Brookline Capital Management - MarketBeat
Verrica Pharmaceuticals (VRCA) Receives Upgrade from Brookline C - GuruFocus
Verrica Pharmaceuticals stock upgraded to Buy by Brookline on pipeline potential - Investing.com Nigeria
Top Premarket Decliners - marketscreener.com
[S-3] Verrica Pharmaceuticals Inc. Shelf Registration Statement | VRCA SEC FilingForm S-3 - Stock Titan
Verrica Pharmaceuticals Earnings Notes - Trefis
Armistice Capital LLC Increases Stock Holdings in Verrica Pharmaceuticals Inc. $VRCA - Defense World
Verrica’s $50 Million PIPE Deal Sparks Big Questions About Its Next Growth Phase - MSN
Verrica Pharmaceuticals Inc. announced that it has received $50.067383 million in funding from BKB Growth Investments, LLC and other investors. - marketscreener.com
How buybacks impact Verrica Pharmaceuticals Inc. stock value2025 Investor Takeaways & Daily Stock Trend Watchlist - Newser
How Verrica Pharmaceuticals Inc. (1NE) stock performs during market turbulenceJuly 2025 Action & Real-Time Sentiment Analysis - Newser
Why Verrica Pharmaceuticals Inc. (1NE) stock appeals to dividend investorsTrade Risk Assessment & Reliable Price Action Trade Plans - Newser
Will Verrica Pharmaceuticals Inc. (1NE) stock extend growth storyJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):